Cargando…
Recent development of AAV-based gene therapies for inner ear disorders
Gene therapy for auditory diseases is gradually maturing. Recent progress in gene therapy treatments for genetic and acquired hearing loss has demonstrated the feasibility in animal models. However, a number of hurdles, such as lack of safe viral vector with high efficiency and specificity, robust d...
Autores principales: | Lan, Yiyang, Tao, Yong, Wang, Yunfeng, Ke, Junzi, Yang, Qiuxiang, Liu, Xiaoyi, Su, Bing, Wu, Yiling, Lin, Chao-Po, Zhong, Guisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445886/ https://www.ncbi.nlm.nih.gov/pubmed/32424232 http://dx.doi.org/10.1038/s41434-020-0155-7 |
Ejemplares similares
-
Correction: Recent development of AAV-based gene therapies for inner ear disorders
por: Lan, Yiyang, et al.
Publicado: (2020) -
AAV-ie enables safe and efficient gene transfer to inner ear cells
por: Tan, Fangzhi, et al.
Publicado: (2019) -
A protective AAV vaccine for SARS-CoV-2
por: Zhao, Simeng, et al.
Publicado: (2022) -
AAV-ie-K558R mediated cochlear gene therapy and hair cell regeneration
por: Tao, Yong, et al.
Publicado: (2022) -
AAV-S: A versatile capsid variant for transduction of mouse and primate inner ear
por: Ivanchenko, Maryna V., et al.
Publicado: (2021)